FDA Adverse Event Injury Summary report: N

OMNIPOD INSULIN PUMP

MDR report key: 3232266 · Received July 9, 2013

Report

Report Number
3004464228-2013-00734
Event Type
Injury
Date Received
July 9, 2013
Date of Event
June 11, 2013
Report Date
June 11, 2013
Manufacturer
INSULET CORPORATION
Product Code
LZG
PMA / PMN Number
K042792
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE WAS NOT RETURNED FOR EVAL. WE ARE UNABLE TO DETERMINE IF ANY MALFUNCTION OR OTHER PRODUCT CONDITION COULD HAVE CONTRIBUTED TO THE REPORTED HOSPITALIZATION FOR DIABETIC KETOACIDOSIS. NO LOT QUALIFICATION RECORDS WERE REVIEWED, AS A PRODUCT LOT NUMBER WAS NOT PROVIDED. THE OMNIPOD USER GUIDE WARNS, "THE OMNIPOD SYSTEM IS DESIGNED TO USE RAPID-ACTING U-100 INSULIN. THE FOLLOWING U-100 RAPID-ACTING INSULIN ANALOGS HAVE BEEN TESTED AND FOUND TO BE SAFE FOR USE IN THE POD: NOVOLOG, HUMALOG, OR APIDRA. BEFORE USING A DIFFERENT INSULIN WITH THE OMNIPOD SYSTEM, CHECK THE INSULIN DRUG LABEL TO MAKE SURE IT CAN BE USED WITH A PUMP. REFER TO THE INSULIN LABELING AND FOLLOW YOUR HEALTHCARE PROVIDER'S DIRECTIONS FOR HOW OFTEN TO REPLACE THE POD" AND "FAILURE TO USE RAPID-ACTING U-100 INSULIN, OR USING INSULIN THAT IS OLD OR INACTIVE, MAY LEAD TO HYPERGLYCEMIA OR DIABETIC KETOACIDOSIS (DKA)."

Description of Event or Problem · 1

AN INSULET CLINICAL SERVICES MGR REPORTED THAT SHE RECEIVED A CALL FROM A REFERRING PHYSICIAN ASKING QUESTIONS ABOUT THE TYPE OF INSULIN USED IN THE POD. HE INFORMED HER THAT HE WAS CALLED IN AS AN EXPERT WITNESS IN A CASE WHERE A PT ALLEGED THAT HIS PRIMARY CARE PHYSICIAN PROVIDED HIM WITH A VIAL OF 75/25 INSULIN TO USE IN THE POD. THE PT PUT THE INSULIN IN THE POD AND EVENTUALLY ENDED UP IN THE HOSPITAL IN DIABETIC KETOACIDOSIS. THE PHYSICIAN STATED THE PT WAS IN (B)(6). BECAUSE IT IS A LEGAL CASE, HE IS SWORN TO CONFIDENTIALITY AND COULD NOT PROVIDE OTHER DETAILS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
312238 OMNIPOD INSULIN PUMP PUMP, INFUSION, INSULIN LZG INSULET CORPORATION 11200

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization